RCE recce pharmaceuticals ltd

News: RCE Recce Pharmaceuticals Says HREC Approval To Start Phase I/II Burns Wound Study

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Oct 16 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :

    • HREC APPROVAL TO START PHASE I/II BURNS WOUND STUDY-RCE.AX
    • GOT HUMAN RESEARCH ETHICS COMMITTEE APPROVAL TO START PHASE I/II CLINICAL TRIAL OF ITS BROAD-SPECTRUM ANTIBIOTIC RECCE 327
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.8¢
Change
0.003(0.65%)
Mkt cap ! $112.0M
Open High Low Value Volume
38.5¢ 39.0¢ 38.0¢ $4.167K 10.76K

Buyers (Bids)

No. Vol. Price($)
2 24610 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 49817 1
View Market Depth
Last trade - 15.44pm 31/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.